ID   ACH10_RAT               Reviewed;         447 AA.
AC   Q9JLB5;
DT   21-JUN-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2000, sequence version 1.
DT   02-OCT-2024, entry version 153.
DE   RecName: Full=Neuronal acetylcholine receptor subunit alpha-10;
DE   AltName: Full=Nicotinic acetylcholine receptor subunit alpha-10;
DE            Short=NACHR alpha-10;
DE   Flags: Precursor;
GN   Name=Chrna10;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, INTERACTION WITH CHRNA9, TISSUE
RP   SPECIFICITY, AND DEVELOPMENTAL STAGE.
RC   STRAIN=Sprague-Dawley;
RX   PubMed=11248107; DOI=10.1073/pnas.051622798;
RA   Elgoyhen A.B., Vetter D.E., Katz E., Rothlin C.V., Heinemann S.F.,
RA   Boulter J.;
RT   "Alpha10: a determinant of nicotinic cholinergic receptor function in
RT   mammalian vestibular and cochlear mechanosensory hair cells.";
RL   Proc. Natl. Acad. Sci. U.S.A. 98:3501-3506(2001).
RN   [2]
RP   FUNCTION, AND INTERACTION WITH CHRNA9.
RX   PubMed=12117536; DOI=10.1016/s0378-5955(02)00380-5;
RA   Weisstaub N., Vetter D.E., Elgoyhen A.B., Katz E.;
RT   "The alpha9alpha10 nicotinic acetylcholine receptor is permeable to and is
RT   modulated by divalent cations.";
RL   Hear. Res. 167:122-135(2002).
RN   [3]
RP   TISSUE SPECIFICITY.
RX   PubMed=12401316; DOI=10.1016/s0306-4522(02)00274-9;
RA   Lips K.S., Pfeil U., Kummer W.;
RT   "Coexpression of alpha 9 and alpha 10 nicotinic acetylcholine receptors in
RT   rat dorsal root ganglion neurons.";
RL   Neuroscience 115:1-5(2002).
RN   [4]
RP   DEVELOPMENTAL STAGE.
RX   PubMed=15356192; DOI=10.1523/jneurosci.2102-04.2004;
RA   Katz E., Elgoyhen A.B., Gomez-Casati M.E., Knipper M., Vetter D.E.,
RA   Fuchs P.A., Glowatzki E.;
RT   "Developmental regulation of nicotinic synapses on cochlear inner hair
RT   cells.";
RL   J. Neurosci. 24:7814-7820(2004).
RN   [5]
RP   FUNCTION, AND INTERACTION WITH CHRNA9.
RX   PubMed=14742688; DOI=10.1124/mol.65.2.453;
RA   Baker E.R., Zwart R., Sher E., Millar N.S.;
RT   "Pharmacological properties of alpha 9 alpha 10 nicotinic acetylcholine
RT   receptors revealed by heterologous expression of subunit chimeras.";
RL   Mol. Pharmacol. 65:453-460(2004).
RN   [6]
RP   SITE HIS-31, AND SUBUNIT.
RX   PubMed=26395518; DOI=10.1038/srep14261;
RA   Xu S., Zhang T., Kompella S.N., Yan M., Lu A., Wang Y., Shao X., Chi C.,
RA   Adams D.J., Ding J., Wang C.;
RT   "Conotoxin alphaD-GeXXA utilizes a novel strategy to antagonize nicotinic
RT   acetylcholine receptors.";
RL   Sci. Rep. 5:14261-14268(2015).
RN   [7]
RP   MUTAGENESIS OF GLU-221 AND PRO-224, AND SUBUNIT.
RX   PubMed=25740413; DOI=10.1124/mol.114.096511;
RA   Azam L., Papakyriakou A., Zouridakis M., Giastas P., Tzartos S.J.,
RA   McIntosh J.M.;
RT   "Molecular interaction of alpha-conotoxin RgIA with the rat alpha9alpha10
RT   nicotinic acetylcholine receptor.";
RL   Mol. Pharmacol. 87:855-864(2015).
RN   [8]
RP   ERRATUM OF PUBMED:25740413.
RX   PubMed=27559150; DOI=10.1124/mol.114.096511err;
RA   Azam L., Papakyriakou A., Zouridakis M., Giastas P., Tzartos S.J.,
RA   McIntosh J.M.;
RT   "Corrections to 'Molecular interaction of alpha-conotoxin RgIA with the rat
RT   alpha9alpha10 nicotinic acetylcholine receptor'.";
RL   Mol. Pharmacol. 90:415-417(2016).
CC   -!- FUNCTION: Ionotropic receptor with a probable role in the modulation of
CC       auditory stimuli. Agonist binding may induce an extensive change in
CC       conformation that affects all subunits and leads to opening of an ion-
CC       conducting channel across the plasma membrane. The channel is permeable
CC       to a range of divalent cations including calcium, the influx of which
CC       may activate a potassium current which hyperpolarizes the cell
CC       membrane. In the ear, this leads to a reduction in basilar membrane
CC       motion, altering the activity of auditory nerve fibers and reducing the
CC       range of dynamic hearing. This may protect against acoustic trauma.
CC       {ECO:0000269|PubMed:11248107, ECO:0000269|PubMed:12117536,
CC       ECO:0000269|PubMed:14742688}.
CC   -!- SUBUNIT: Forms heterooligomeric channels in conjunction with CHRNA9.
CC       The native outer hair cell receptor may be composed of CHRNA9-CHRNA10
CC       heterooligomers. Interacts with the conotoxin GeXXA (PubMed:26395518).
CC       Interacts with the alpha-conotoxin RgIA (PubMed:25740413).
CC       {ECO:0000269|PubMed:25740413, ECO:0000269|PubMed:26395518}.
CC   -!- SUBCELLULAR LOCATION: Postsynaptic cell membrane {ECO:0000305}; Multi-
CC       pass membrane protein {ECO:0000305}. Cell membrane {ECO:0000305};
CC       Multi-pass membrane protein {ECO:0000305}.
CC   -!- TISSUE SPECIFICITY: Expressed in the outer hair cells of the cochlea
CC       and the neurons of dorsal root ganglia. {ECO:0000269|PubMed:11248107,
CC       ECO:0000269|PubMed:12401316}.
CC   -!- DEVELOPMENTAL STAGE: Expression in the inner hair cells of the ear is
CC       lost at the onset of hearing, around P12. This correlates with a loss
CC       of sensitivity of these cells to cholinergic stimuli.
CC       {ECO:0000269|PubMed:11248107, ECO:0000269|PubMed:15356192}.
CC   -!- MISCELLANEOUS: The heterooligomeric receptor composed of CHRNA9 and
CC       CHRNA10 has an atypical pharmacological profile, binding several non-
CC       nicotinic ligands including strychnine (a glycine receptor antagonist)
CC       and atropine (a muscarinic acetylcholine receptor antagonist).
CC   -!- SIMILARITY: Belongs to the ligand-gated ion channel (TC 1.A.9) family.
CC       Acetylcholine receptor (TC 1.A.9.1) subfamily. Alpha-10/CHRNA10 sub-
CC       subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF196344; AAF27624.1; -; mRNA.
DR   RefSeq; NP_072161.1; NM_022639.1.
DR   RefSeq; XP_017445156.1; XM_017589667.1.
DR   AlphaFoldDB; Q9JLB5; -.
DR   SMR; Q9JLB5; -.
DR   ComplexPortal; CPX-224; Neuronal nicotinic acetylcholine receptor complex, alpha9-alpha10.
DR   STRING; 10116.ENSRNOP00000027506; -.
DR   BindingDB; Q9JLB5; -.
DR   ChEMBL; CHEMBL3461; -.
DR   DrugCentral; Q9JLB5; -.
DR   GuidetoPHARMACOLOGY; 470; -.
DR   GlyCosmos; Q9JLB5; 2 sites, No reported glycans.
DR   GlyGen; Q9JLB5; 2 sites.
DR   PhosphoSitePlus; Q9JLB5; -.
DR   PaxDb; 10116-ENSRNOP00000027506; -.
DR   Ensembl; ENSRNOT00000027507.4; ENSRNOP00000027506.2; ENSRNOG00000020293.4.
DR   Ensembl; ENSRNOT00055050674; ENSRNOP00055041751; ENSRNOG00055029243.
DR   Ensembl; ENSRNOT00060005586; ENSRNOP00060004087; ENSRNOG00060003393.
DR   Ensembl; ENSRNOT00065039893; ENSRNOP00065032438; ENSRNOG00065023352.
DR   GeneID; 64574; -.
DR   KEGG; rno:64574; -.
DR   UCSC; RGD:620142; rat.
DR   AGR; RGD:620142; -.
DR   CTD; 57053; -.
DR   RGD; 620142; Chrna10.
DR   eggNOG; KOG3645; Eukaryota.
DR   GeneTree; ENSGT00940000160721; -.
DR   HOGENOM; CLU_018074_0_0_1; -.
DR   InParanoid; Q9JLB5; -.
DR   OMA; IFFCMAL; -.
DR   OrthoDB; 5489962at2759; -.
DR   PhylomeDB; Q9JLB5; -.
DR   TreeFam; TF315605; -.
DR   PRO; PR:Q9JLB5; -.
DR   Proteomes; UP000002494; Chromosome 1.
DR   Bgee; ENSRNOG00000020293; Expressed in spleen.
DR   GO; GO:0030424; C:axon; IDA:RGD.
DR   GO; GO:0098981; C:cholinergic synapse; IDA:SynGO.
DR   GO; GO:0043005; C:neuron projection; IBA:GO_Central.
DR   GO; GO:0043204; C:perikaryon; IDA:RGD.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0099634; C:postsynaptic specialization membrane; IDA:SynGO.
DR   GO; GO:0045202; C:synapse; IBA:GO_Central.
DR   GO; GO:1902495; C:transmembrane transporter complex; IBA:GO_Central.
DR   GO; GO:0022848; F:acetylcholine-gated monoatomic cation-selective channel activity; ISO:RGD.
DR   GO; GO:0005262; F:calcium channel activity; IEA:UniProtKB-KW.
DR   GO; GO:0004888; F:transmembrane signaling receptor activity; IEA:InterPro.
DR   GO; GO:1904315; F:transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential; IDA:SynGO.
DR   GO; GO:0007268; P:chemical synaptic transmission; ISO:RGD.
DR   GO; GO:0099565; P:chemical synaptic transmission, postsynaptic; ISO:RGD.
DR   GO; GO:0050910; P:detection of mechanical stimulus involved in sensory perception of sound; ISO:RGD.
DR   GO; GO:0060079; P:excitatory postsynaptic potential; ISO:RGD.
DR   GO; GO:0042472; P:inner ear morphogenesis; ISO:RGD.
DR   GO; GO:0051899; P:membrane depolarization; ISO:RGD.
DR   GO; GO:0098655; P:monoatomic cation transmembrane transport; ISO:RGD.
DR   GO; GO:0070373; P:negative regulation of ERK1 and ERK2 cascade; IMP:RGD.
DR   GO; GO:0007204; P:positive regulation of cytosolic calcium ion concentration; ISO:RGD.
DR   GO; GO:0010996; P:response to auditory stimulus; ISO:RGD.
DR   GO; GO:0007271; P:synaptic transmission, cholinergic; ISO:RGD.
DR   CDD; cd19051; LGIC_TM_cation; 1.
DR   Gene3D; 2.70.170.10; Neurotransmitter-gated ion-channel ligand-binding domain; 1.
DR   Gene3D; 1.20.58.390; Neurotransmitter-gated ion-channel transmembrane domain; 2.
DR   InterPro; IPR006202; Neur_chan_lig-bd.
DR   InterPro; IPR036734; Neur_chan_lig-bd_sf.
DR   InterPro; IPR006201; Neur_channel.
DR   InterPro; IPR036719; Neuro-gated_channel_TM_sf.
DR   InterPro; IPR038050; Neuro_actylchol_rec.
DR   InterPro; IPR006029; Neurotrans-gated_channel_TM.
DR   InterPro; IPR018000; Neurotransmitter_ion_chnl_CS.
DR   InterPro; IPR002394; Nicotinic_acetylcholine_rcpt.
DR   NCBIfam; TIGR00860; LIC; 1.
DR   PANTHER; PTHR18945:SF889; NEURONAL ACETYLCHOLINE RECEPTOR SUBUNIT ALPHA-10; 1.
DR   PANTHER; PTHR18945; NEUROTRANSMITTER GATED ION CHANNEL; 1.
DR   Pfam; PF02931; Neur_chan_LBD; 1.
DR   Pfam; PF02932; Neur_chan_memb; 1.
DR   PRINTS; PR00254; NICOTINICR.
DR   PRINTS; PR00252; NRIONCHANNEL.
DR   SUPFAM; SSF90112; Neurotransmitter-gated ion-channel transmembrane pore; 1.
DR   SUPFAM; SSF63712; Nicotinic receptor ligand binding domain-like; 1.
DR   PROSITE; PS00236; NEUROTR_ION_CHANNEL; 1.
PE   1: Evidence at protein level;
KW   Calcium; Calcium channel; Calcium transport; Cell membrane; Disulfide bond;
KW   Glycoprotein; Ion channel; Ion transport; Ligand-gated ion channel;
KW   Membrane; Postsynaptic cell membrane; Receptor; Reference proteome; Signal;
KW   Synapse; Transmembrane; Transmembrane helix; Transport.
FT   SIGNAL          1..24
FT                   /evidence="ECO:0000255"
FT   CHAIN           25..447
FT                   /note="Neuronal acetylcholine receptor subunit alpha-10"
FT                   /id="PRO_0000000377"
FT   TOPO_DOM        25..237
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        238..258
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        268..288
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        302..322
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        323..425
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        426..446
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   SITE            31
FT                   /note="Involved in the interaction with the conotoxin
FT                   GeXXA"
FT                   /evidence="ECO:0000269|PubMed:26395518"
FT   CARBOHYD        40
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        56
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        154..168
FT                   /evidence="ECO:0000250"
FT   DISULFID        218..219
FT                   /note="Associated with receptor activation"
FT                   /evidence="ECO:0000250"
FT   MUTAGEN         221
FT                   /note="E->Q: CHRNA9-CHRNA10 receptor is 25-fold less
FT                   potently inhibited by the alpha-conotoxin RgIA."
FT                   /evidence="ECO:0000269|PubMed:25740413"
FT   MUTAGEN         224
FT                   /note="P->Q: CHRNA9-CHRNA10 receptor is 300-fold less
FT                   potently inhibited by the alpha-conotoxin RgIA."
FT                   /evidence="ECO:0000269|PubMed:25740413"
SQ   SEQUENCE   447 AA;  49820 MW;  EEE49D93490B698F CRC64;
     MGTRSHYLDL GFLLLLFLPA ECLGAEGRLA HKLFRDLFAN YTSALRPVAD TDQTLNVTLE
     VTLSQIIDMD ERNQVLTLYL WIRQEWTDAY LHWDPKAYGD LDAIRIPSRL VWRPDIVLYN
     KADTQPPASA STNVVVRHDG AVRWDAPAIT RSSCRVDVSA FPFDAQRCGL TFGSWTHGGH
     QLDVRPRGTS ASLADFVENV EWRVLGMPAR RRVLTYGCCS EPYPDVTFTL LLRRRAAAYV
     CNLLLPCVFI SLLAPLAFHL PADSGEKVSL GVTVLLALTV FQLILAESMP PAESVPLIGK
     YYMATMTMVT FSTALTILIM NLHYCGPNAH PVPAWARVLL LGHLAKGLCV RERGEPCGQS
     KPLESAPSLQ PPPASPAGPC HEPRCLCHQE ALLHHIASIA STFRSHRAAQ RRHEDWKRLA
     RVMDRFFLGI FFCMALVMSL IVLVQAL
//
